C6orf134 Inhibitors
C6orf134, also known as chromosome 6 open reading frame 134, is a gene about which relatively little is understood in the scientific community. While its precise function remains enigmatic like many other genes, C6orf134 is involved in a myriad of cellular processes, possibly including cell signaling, gene regulation, or intracellular trafficking. The expression of C6orf134, as with any gene, is subject to the cell's rigorous regulatory mechanisms, which are designed to fine-tune protein levels in response to various physiological needs and environmental stimuli. Understanding the expression patterns of C6orf134 could shed light on its potential roles and how it might interact with other cellular components to perform its functions.
In the realm of molecular biology research, there exists a suite of chemicals known for their ability to inhibit gene expression at various stages, from transcription to translation. For instance, Trichostatin A and 5-Azacytidine are compounds that can alter chromatin structure and DNA methylation patterns, respectively, potentially leading to a decrease in gene transcription. Actinomycin D and Alpha-amanitin are known to directly impede the transcriptional machinery, thereby reducing mRNA synthesis of targeted genes. Transcriptional interference is just one facet of gene expression control; post-transcriptionally, chemicals like Cycloheximide and Pladienolide B disrupt mRNA translation and splicing, respectively, leading to decreased protein synthesis. It is essential to acknowledge that these chemicals are not selective for C6orf134 and would likely influence the expression of multiple genes. This non-selectivity is a crucial consideration for researchers, as the global modulation of gene expression can yield complex physiological outcomes due to the interconnectivity of cellular pathways. The application of such inhibitors to study C6orf134 would aim to unravel the gene's role by observing the cellular consequences of reducing its expression, thereby contributing to the broader understanding of its biological significance.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could reduce the transcription of C6orf134 by enhancing chromatin condensation, thereby making the gene less accessible to transcriptional machinery. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By disrupting the normal methylation pattern of the C6orf134 gene promoter, 5-Azacytidine could lead to the recruitment of repressive transcriptional complexes that silence this gene's expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D, through intercalation into DNA, could specifically obstruct the transcriptional progression of RNA polymerase at the C6orf134 gene, thereby decreasing mRNA levels for this protein. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Through the inhibition of the mTOR pathway, Rapamycin could downregulate the expression of C6orf134 by decreasing the translation of mRNAs of proteins that control the gene's transcription. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide could inhibit the elongation phase of mRNA translation, leading to a reduction in the overall synthesis of the C6orf134 protein. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Alpha-amanitin could selectively inhibit RNA polymerase II, leading to a decrease in the transcriptional output of the C6orf134 gene. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB could inhibit the phosphorylation of the C-terminal domain of RNA polymerase II, leading to a selective decrease in the transcription of the C6orf134 gene. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
By inhibiting Topoisomerase I, Camptothecin could create a blockade during the transcription of the C6orf134 gene, resulting in reduced mRNA synthesis. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can elevate lysosomal pH, which might disrupt lysosomal degradation pathways involved in the turnover of transcriptional regulators, thus decreasing the expression of C6orf134. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
By displacing bromodomain-containing proteins from chromatin, JQ1 could decrease the transcriptional initiation and elongation of the C6orf134 gene. | ||||||